Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.42 - $0.72 $6,187 - $10,607
-14,732 Reduced 25.4%
43,258 $27,000
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $17,661 - $45,035
-29,435 Reduced 33.67%
57,990 $34,000
Q2 2023

Aug 21, 2023

SELL
$1.05 - $1.63 $216,248 - $335,700
-205,951 Reduced 70.2%
87,425 $98,000
Q1 2023

May 09, 2023

BUY
$1.2 - $2.73 $2,289 - $5,208
1,908 Added 0.65%
293,376 $396,000
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $18,483 - $39,020
10,809 Added 3.85%
291,468 $542,000
Q3 2022

Nov 18, 2022

SELL
$1.9 - $8.63 $19,965 - $90,684
-10,508 Reduced 3.61%
280,659 $690,000
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $49,597 - $209,797
23,285 Added 8.69%
291,167 $710,000
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $96,096 - $238,558
-15,302 Reduced 5.4%
267,882 $2.14 Million
Q4 2021

Feb 15, 2022

BUY
$14.7 - $28.67 $282,798 - $551,553
19,238 Added 7.29%
283,184 $4.32 Million
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $296,193 - $409,382
-12,184 Reduced 4.41%
263,946 $7.5 Million
Q2 2021

Aug 16, 2021

BUY
$26.09 - $40.4 $2.43 Million - $3.77 Million
93,223 Added 50.97%
276,130 $9.31 Million
Q1 2021

May 18, 2021

BUY
$33.06 - $56.93 $270,364 - $465,573
8,178 Added 4.68%
182,907 $6.99 Million
Q4 2020

Feb 16, 2021

SELL
$39.09 - $57.4 $1,172 - $1,722
-30 Reduced 0.02%
174,729 $7.31 Million
Q3 2020

Nov 17, 2020

BUY
$28.43 - $44.67 $20,640 - $32,430
726 Added 0.42%
174,759 $7.58 Million
Q2 2020

Aug 17, 2020

BUY
$11.71 - $30.29 $505,333 - $1.31 Million
43,154 Added 32.97%
174,033 $5.27 Million
Q1 2020

May 13, 2020

SELL
$7.64 - $27.5 $11,276 - $40,590
-1,476 Reduced 1.12%
130,879 $1.79 Million
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $40,163 - $55,004
-2,674 Reduced 1.98%
132,355 $2.14 Million
Q3 2019

Nov 15, 2019

BUY
$18.85 - $27.5 $30,405 - $44,357
1,613 Added 1.21%
135,029 $2.6 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $431,887 - $653,177
24,864 Added 22.91%
133,416 $3.14 Million
Q1 2019

May 09, 2019

BUY
$10.65 - $25.75 $54,485 - $131,737
5,116 Added 4.95%
108,552 $2.54 Million
Q4 2018

Feb 13, 2019

BUY
$9.26 - $16.38 $28,400 - $50,237
3,067 Added 3.06%
103,436 $1.14 Million
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $19,950 - $48,448
2,646 Added 2.71%
100,369 $1.68 Million
Q2 2018

Aug 14, 2018

BUY
$4.87 - $8.42 $155,080 - $268,126
31,844 Added 48.34%
97,723 $718,000
Q1 2018

May 15, 2018

SELL
$4.69 - $10.05 $6,148 - $13,175
-1,311 Reduced 1.95%
65,879 $309,000
Q4 2017

Feb 14, 2018

BUY
$7.86 - $9.99 $32,446 - $41,238
4,128 Added 6.55%
67,190 $610,000
Q3 2017

Nov 13, 2017

BUY
$8.89 - $10.4 $560,621 - $655,844
63,062
63,062 $591,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.